aneuploidy Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year Premium During a conference call, company executives also discussed results from the SMART NIPT trial and their outlook for Natera's three businesses. Natera Revenues Grow 35 Percent in Q4 The company reported $112.4 million in revenues compared to $83.2 million in Q4 2019, beating the average Wall Street estimate of $106.6 million. At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing Last year, the company processed more than 1 million tests, most of them for its reproductive health business, but interest in Prospera and Signatera is growing. UnitedHealthcare to Cover NIPT for Average-Risk Pregnancies Several analysts said that the decision by UHC, the largest private payor in the US, will especially benefit Natera. Myriad Genetics Bets Fetal DNA Enrichment Method Will Further Increase Uptake of NIPS Test Premium In a study involving 1,300 blood samples from pregnant women, Myriad researchers demonstrated that their method could increase the fetal fraction for almost all. Nov 6, 2020 Natera Expects Further Growth in NIPT as it Expands Use Cases for Cancer, Transplant Tests Premium Oct 29, 2020 Humana Broadens Coverage of NIPT for Average Risk Pregnancies Oct 26, 2020 Yourgene H1 Revenues Up 5 Percent Sep 21, 2020 Yourgene Inks US Distribution Deal for Chemotoxicity Assay, Other Tests Sep 17, 2020 SVB Leerink Initiates Coverage of Natera With Outperform Rating Aug 17, 2020 ACOG Guidelines Recommend NIPT for All Pregnancies Regardless of Risk Aug 5, 2020 Natera Revenues Climb 16 Percent in Q2 Driven by Reproductive Health Business Jul 28, 2020 Yourgene Health Records £2.3M Net Loss for Fiscal Year 2020 Jul 13, 2020 Thermo Fisher Scientific, First Genetics to Develop NGS-Based Diagnostics in Russia Jul 9, 2020 Aneuploidy Common in Early-Stage Human Embryos, Single-Cell RNA-Seq Study Reveals Jul 7, 2020 Progenity Asks Court to Declare Non-Infringement of Natera Patents Jun 3, 2020 Sperm Single-Cell Sequencing Study Offers Insight Into Meiotic Variation May 12, 2020 Natera and Illumina Settle Patent Suit, Sign License Agreement, Amend Supply Deal May 6, 2020 Natera Q1 Revenues Grow 41 Percent Apr 20, 2020 Yourgene Health Fiscal 2020 Revenues Up 86 Percent Apr 13, 2020 Natera Expects 35 Percent Rise in Q1 Revenues, Proposes $250M Senior Notes Offering Mar 10, 2020 Yourgene Health Acquiring French Distributor of NIPT Test for up to €4.1M Dec 17, 2019 PerkinElmer Aims to Attract Vanadis NIPT Customers Through Service, Validation Studies Premium Dec 11, 2019 Study Shows Feasibility of Circulating Trophoblast-Based Noninvasive Prenatal Testing Premium Dec 2, 2019 Yourgene Health Revenues Nearly Double in H1 of FY2019 Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.